Scientists pave the way for fast, cost-effective custom enzyme development
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Oct-2026 14:17 ET (24-Oct-2026 18:17 GMT/UTC)
Enzymes are essential in industries such as food production and pharmaceuticals, but natural enzymes often need improvements for commercial applications. Researchers in Japan have developed an in vitro selection platform, SMART, which could produce custom enzyme much more quickly and cost-effectively than conventional methods.
A new UNU-INWEH report warns that the global rush for critical minerals needed for EVs, renewable energy, and AI is driving severe but often hidden water, health, and environmental harms in vulnerable communities, especially in Africa and South America. The report calls for binding global standards, stronger accountability, and fairer benefit-sharing to prevent the clean energy transition from repeating the injustices of the fossil fuel era.
Researchers revealed how zinc levels control the endoplasmic reticulum (ER), the cell’s primary protein factory, and how it fundamentally regulates cellular proteostasis. Using fluorescent probes, they found that the transporter ZIP7 keeps zinc levels in the ER low. When ZIP7 is disrupted, zinc level surges, inhibiting the enzyme Ero1 and disrupting the cell’s redox balance. This prevents proteins from folding correctly, leading to an array of pathologies including cancer.
Oxygen transport, a vital process for sustaining life, is carried out by red blood cells that deliver oxygen to tissues through microscopic capillary networks. Now, researchers from Kyushu University and Institute of Science Tokyo have developed a computational model that simulates this process by combining blood flow, chemical reactions, and oxygen consumption within one system. These simulations reveal that RBCs can adjust the amount of oxygen released based on surrounding oxygen levels, thereby maintaining a stable oxygen concentration across tissues.
Utilizing mice, researchers have identified the "organizer cells" responsible for building bone during fetal development. The study reveals a two-phase program led by RANKL-producing "organizer cells": early-stage septoclasts clear cartilage to create space, followed by LepR+ bone marrow stromal cells that sustain the marrow environment. This developmental blueprint is reactivated during fracture healing, offering a novel therapeutic target for bone diseases like osteoporosis by focusing on niche cells rather than the bone-destroying cells themselves.
Researchers from the National Institute for Physiological Sciences, Nagoya City University, and Tokyo Metropolitan Institute of Medical Science in Japan have discovered ion channel molecules that respond directly to extracellular potassium, revealing a similar potassium-binding mechanism in fruit flies and humans. This discovery may point to previously unexplored mechanisms for sensing extracellular K⁺ and its homeostasis, potentially leading to new therapeutic targets.